Yrigoyen Dan 4
4 · Arch Therapeutics, Inc. · Filed Aug 11, 2021
Insider Transaction Report
Form 4
Yrigoyen Dan
Vice President, Sales
Transactions
- Award
Common Stock
2021-07-30+150,000→ 150,000 total - Award
Stock Option (right to buy)
2021-07-30+150,000→ 150,000 totalExercise: $0.09Exp: 2031-07-29→ Common Stock (150,000 underlying)
Footnotes (2)
- [F1]1/3 of the Shares (50,000) shall vest on each of the six (6), twelve (12) and eighteen month anniversaries of 7/12/2021, the vesting commencement date.
- [F2]The Shares subject to the Option, 1/3 (50,000) shall vest on the anniversary of the vesting commencement date (7/12/21), and 1/24 of the remaining shares shall vest on each of the next twenty-four monthly anniversaries 7/12/2022, subject to continued service to the Company through each vesting date. In the event of a Change of Control (as such term is defined in the Plan), then, in any such case, 100% of the number of unvested shares then subject to the option and then subject to any other then-outstanding stock option or other equity award that may have been granted under or outside of the Plan shall accelerate and become vested as of the date of such event.